Point72 Asset Management L.P. decreased its holdings in shares of Omega Healthcare Investors Inc (NYSE:OHI) by 86.7% during the third quarter, according to its most recent filing with the SEC. The firm owned 12,700 shares of the real estate investment trust’s stock after selling 83,123 shares during the period. Point72 Asset Management L.P.’s holdings in Omega Healthcare Investors were worth $531,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Vanguard Group Inc. boosted its stake in shares of Omega Healthcare Investors by 5.6% during the second quarter. Vanguard Group Inc. now owns 31,995,715 shares of the real estate investment trust’s stock valued at $1,175,842,000 after purchasing an additional 1,686,492 shares in the last quarter. BlackRock Inc. increased its holdings in Omega Healthcare Investors by 2.5% during the second quarter. BlackRock Inc. now owns 24,907,576 shares of the real estate investment trust’s stock valued at $915,351,000 after buying an additional 600,319 shares during the period. Bank of New York Mellon Corp increased its holdings in Omega Healthcare Investors by 2.0% during the second quarter. Bank of New York Mellon Corp now owns 5,048,815 shares of the real estate investment trust’s stock valued at $185,543,000 after buying an additional 98,805 shares during the period. Daiwa Securities Group Inc. raised its stake in Omega Healthcare Investors by 8,172.1% in the third quarter. Daiwa Securities Group Inc. now owns 3,386,672 shares of the real estate investment trust’s stock worth $141,529,000 after buying an additional 3,345,731 shares in the last quarter. Finally, Invesco Ltd. raised its stake in Omega Healthcare Investors by 19.0% in the second quarter. Invesco Ltd. now owns 3,204,955 shares of the real estate investment trust’s stock worth $117,781,000 after buying an additional 512,093 shares in the last quarter. 75.27% of the stock is currently owned by institutional investors and hedge funds.

Shares of OHI opened at $42.29 on Friday. The company has a 50 day moving average of $42.61 and a two-hundred day moving average of $39.61. The company has a quick ratio of 3.00, a current ratio of 3.00 and a debt-to-equity ratio of 1.13. Omega Healthcare Investors Inc has a twelve month low of $33.39 and a twelve month high of $45.01. The company has a market cap of $9.17 billion, a price-to-earnings ratio of 13.91, a price-to-earnings-growth ratio of 5.61 and a beta of 0.31.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.73 by ($0.10). The business had revenue of $199.00 million for the quarter, compared to analyst estimates of $194.26 million. Omega Healthcare Investors had a return on equity of 8.76% and a net margin of 38.12%. The business’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.77 earnings per share. On average, sell-side analysts expect that Omega Healthcare Investors Inc will post 2.99 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Thursday, October 31st were given a dividend of $0.67 per share. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.66. This represents a $2.68 annualized dividend and a yield of 6.34%. The ex-dividend date of this dividend was Wednesday, October 30th. Omega Healthcare Investors’s dividend payout ratio is currently 88.16%.

In other Omega Healthcare Investors news, CAO Michael Ritz sold 2,500 shares of the stock in a transaction dated Wednesday, September 25th. The stock was sold at an average price of $42.00, for a total value of $105,000.00. Following the completion of the sale, the chief accounting officer now directly owns 5,485 shares in the company, valued at $230,370. The transaction was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 1.16% of the company’s stock.

Several analysts have issued reports on the company. Bank of America reaffirmed a “buy” rating and set a $44.50 target price on shares of Omega Healthcare Investors in a research report on Monday, October 14th. Zacks Investment Research upgraded Omega Healthcare Investors from a “sell” rating to a “hold” rating in a report on Wednesday, November 13th. Wells Fargo & Co boosted their price target on Omega Healthcare Investors from $36.00 to $40.00 and gave the stock a “market perform” rating in a research report on Friday, August 23rd. Berenberg Bank initiated coverage on Omega Healthcare Investors in a research note on Thursday, September 12th. They set a “buy” rating and a $47.00 price objective for the company. Finally, Raymond James downgraded Omega Healthcare Investors from a “strong-buy” rating to a “market perform” rating in a research report on Monday, October 21st. Six analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $41.98.

Omega Healthcare Investors Profile

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Read More: What causes a recession?

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors Inc (NYSE:OHI).

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.